Cargando...
Recommendations for Clinical Trial Development in Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) comprises around 6% of all non-Hodgkin’s lymphoma (NHL) diagnoses. In younger patients, age less than 60 to 65 years, aggressive induction often followed by consolidation with autologous stem cell transplant has suggested improved outcomes in this population. Less intensiv...
Gardado en:
| Publicado en: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6059122/ https://ncbi.nlm.nih.gov/pubmed/28040733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw263 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|